Black lung cancer patients less likely to get tested with latest genomic analysis technology
Black patients diagnosed with metastatic non-small cell lung cancer since 2017 were less likely than White patients to be tested for biomarkers that can guide treatment, according to a study of 64,000 medical records led by Debora Bruno of Case Western Reserve University (above). Black patients were less likely to ever undergo throughout their diagnosis […]